Zero Tolerance Anti-Doping Newsletter
Volume 2, Issue 6 - September 2005
In This Issue
USA Track & Field CEO Craig A. Masback and USATF President Bill Roe developed the plan in concert with the USATF Board of Directors in October 2003 by combining existing programs and USATF priorities with ambitious new initiatives. "Zero Tolerance" focuses on three goals: increasing efforts to catch and punish cheaters; expanding educational efforts and focusing the message on the theme that cheating is wrong and cheaters will be caught; and taking a more visible role on these issues.
The World Anti-Doping Agency (WADA) recently announced the 2006 Prohibited List, which will go into effect on January 1, 2006. Below are some of the key changes that may affect you directly. For the complete list, please go to www.wada-ama.org.
Substances and Methods Prohibited at All Times (In- and Out-of Competition)
S1. Anabolic Agents
1. Anabolic androgenic steroids
Desoxymethyltestosterone (designer steroid), methasterone, prostanozol and methyl-1-testosterone are added to the list of examples.
As described in the Explanatory Note of the 2005 List, that an Adverse Analytical Finding for 19-norandrosterone reported by a laboratory is sufficient proof and does not require further follow-up tests.
Clarifies that drosperinone, a progestative with mild diuretic properties, is not prohibited (as indicated in the Explanatory Note of the 2005 Prohibited List).
Substances and Methods Prohibited In-Competition
Adrenaline, which previously was exemplified in a footnote only, is now clearly named in the list of stimulants.
Some stimulants considered prohibited but not previously listed as examples in the 2004 and 2005 List, are re-introduced to the list of examples for clarification. Therefore, cropropamide, crotetamide, etamivan, heptaminol, isometheptene, and the isomers of methylamphetamine (levmethamfetamine, methamphetamine (D-), p- methamphetamine, ortetamine, phenpromethamine, propylhexedrine) are re-introduced as examples.
New examples of stimulants are added based on chemical structure or biological effect(s): cyclazodone, fenbutrazate, meclofenoxate, norfenefrine, octopamine, oxilofrine, pentetrazol, sibutramine.
Topical preparations, to treat aural/otic, nasal, buccal cavity and ophthalmic ailments, no longer require a Therapeutic Use Exemption due to a wide medical use and the absence of doping potential for these routes of administration.
If you need to take a medication that contains a prohibited substance, you must complete the proper paperwork - either an Abbreviated Therapeutic Use Exemption (ATUE) or a Therapeutic Use Exemption (TUE) - before competing at an event where you could be subject to doping control.
If you have questions regarding which form you need to complete or the application process - please contact USADA's Betsy Liebsch at 719-785-2045.
USADA announced their second quarter doping control test results on September 2, with track and field athletes undergoing 716 total tests, nearly 30 percent of USADA's 2,575 overall tests. Track and field nearly triples the next highest-tested sport swimming (260).
More than 93 percent of the tests were performed with no-advance notice to the athletes. In second quarter, USADA announced six anti-doping rules violations, including one suspension involving the use of r-EPO, one suspension for the use of a stimulant, two suspensions for the prohibited use of cannabis, one suspension involving a beta-2 agonist and another suspension for blood doping. Of the suspensions announced in the 2nd quarter, only one involved a track and field athlete.
For more information on USADA's testing statistics visit www.usantidoping.org.
The 10th IAAF World Championships in Athletics was the largest anti-doping program ever conducted by the IAAF, nearly doubling the number of doping control tests at the Paris World Championships in 2003.
The 2005 edition of the World Championships, which took place in Helsinki between August 6-14, saw over 850 tests conducted, both before and during the competition. It was the largest testing program ever conducted at an IAAF World Championships.
Nearly half of all athletes competing were tested during the Championships. Approximately 350 competitors were blood screened as they entered the athlete's village, while during the championships themselves, close to 500 tests were collected - more than 50 tests for every day of competition. Also in competition, about 100 blood tests were carried out for the detection of Blood Transfusion, Hemoglobin Based Oxygen Carriers (Hbocs) and other substances.
September was a month of re-vamping for the U.S. Anti-Doping Agency, including the unveiling of a new logo for the organization. The red, white and blue coloring and the stars and stripes in the new mark symbolize USADA's position as the independent, anti-doping agency for the United States Olympic and Paralympic Movement. The mark also represents USADA's dedication to fair play, a fair process and a level playing field. The words "integrity, health, and sport" serve as a reminder of USADA's mission - to preserve the well-being of Olympic Sport, the integrity of competition, and ensuring the health of athletes. Also on September 1, USADA opened shop at a new office, still in Colorado Springs. Their new mailing address will be 1330 Quail Lake Loop, Suite 260, Colorado Springs, CO 80906. The phone and fax numbers, as well as staff e-mail addresses, all remain the same.
Get your advantage with USADA's Athlete's Advantage program, which provides tools and resources to athletes more easily comply with anti-doping rules and policies.
The Athlete's Advantage Toolkit is a handy three-ring calendar binder containing important USADA publications, and is available to athletes in the Out-of-Competition (OOC) testing program. USADA launched the Athlete's Advantage Online to help athletes in the OOC testing program to learn how and where to access anti-doping resources. Athletes in the OOC testing program can sign up to receive the Toolkit while going through the Online project, by e-mailing email@example.com or calling (866) 601-2632 x 2044 or 719-785-2044. USADA publications are available to all athletes.
Get your advantage now by visiting www.usantidoping.org/advantage. For information about permitted and prohibited medications, use USADA's Drug Reference Online - www.usantidoping.org/dro, or call the Drug Reference Line at (800) 233-0393.
|Oct. 1||IAAF World Half Marathon Championships|
|Oct. 2||USA Marathon Championships|
|Oct. 5||USA 5 km Race Walk Championships|
|Oct. 9||Chicago Marathon|
|Oct. 10||USA Women's 10 km Championship|
|Oct. 23||North American 5 km Team Challenge|
|Nov. 5||USA Men's 10 km Championship|
|Nov. 6||New York City Marathon|
|Nov. 19||USATF National Club Cross Country Championships|
|Nov. 22||International Chiba Ekiden|
|Nov. 30 - Dec. 4||USATF Annual Meeting|